🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03274830
Active, not recruiting Observational

A Post Market Clinical Follow-up Study With the aneXys Cup

NCT03274830 · tracked via the Priya Life Science Germany tracker
Sponsor
Mathys Ltd Bettlach
Phase
Observational
Started
2020-03-05
Last updated
2026-02-06

Condition(s) studied

Arthroplasty, Replacement, Hip

Investigational drug(s) / intervention(s)

aneXys

aneXys: 150 patients with the aneXys cup

Study summary

The purpose of the study is the evaluation of the clinical and radiological short- to long-term safety and performance of the aneXys cup. The data will be used for an ongoing evaluation of the product safety and performance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Informed consent form (signed by participant and investigator) * Primary implantation * Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible. * Age at inclusion: between 18 and 75 years old * Willing to participate in the follow-up examinations * Complete recovery is expected Exclusion Criteria: * Missing informed consent form (signed by participant and investigator) * Known or suspected non-compliance (e.g. drug or alcohol abuse) * Enrolment of the investigator, his/her family, employees and other dependent persons * Patients younger 18 years old * Revision surgery * Presence of sepsis or malignant tumours * ASA (American Society of Anesthesiologists) Classification \>3 * Pregnancy

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
DRK Kliniken Berlin | Köpernick Berlin Germany
DRK Kliniken Berlin | Westend Berlin Germany
Universitätsklinikum Leipzig Leipzig Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03274830 on ClinicalTrials.gov ↗ ← All trials in Germany